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Abstract 
Subchondral bone sclerosis is a well-recognised manifestation of osteoarthritis (OA). The 
osteocyte cell network is now considered to be central to the regulation of bone homeo-
stasis; however, it is not known whether the integrity of the osteocyte cell network is altered 
in OA patients. The aim of this study was to investigate OA osteocyte phenotypic changes and 
its potential role in OA subchondral bone pathogenesis. The morphological and phenotypic 
changes of osteocytes in OA samples were investigated by micro-CT, SEM, histology, im-
munohistochemistry,  TRAP  staining,  apoptosis  assay  and  real-time  PCR  studies.  We 
demonstrated that in OA subchondral bone, the osteocyte morphology was altered showing 
rough and rounded cell body with fewer and disorganized dendrites compared with the os-
teocytes in control samples. OA osteocyte also showed dysregulated expression of osteocyte 
markers, apoptosis, and degradative enzymes, indicating that the phenotypical changes in OA 
osteocytes were accompanied with OA subchondral bone remodelling (increased osteoblast 
and osteoclast activity) and increased bone volume with altered mineral content. Significant 
alteration of osteocytes identified in OA samples indicates a potential regulatory role of 
osteocytes in subchondral bone remodelling and mineral metabolism during OA pathogene-
sis. 
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INTRODUCTION 
Osteoarthritis  (OA)  is  the  most  common  mus-
culo-skeletal  disorder,  yet  the  aetiology  is  still  un-
known.  Regardless  of  the  aetiology  the  disease  is 
progressive  and  is  characterised  by  a  series  of  pre-
dictable clinical and radiological changes. More than 
30 years ago, Radin et al suggested that an increase in 
stiffness of subchondral bone, rendering it less capa-
ble of attenuating and distributing load throughout 
the  joint,  increased  stress  in  the  overlying  articular 
cartilage, leading to the deterioration in OA (1, 2). One 
of  the  earliest  changes  seen  radiographically,  often 
before any joint space narrowing is observed, is sub-
chondral bone sclerosis. This sclerosis is recognised as 
a  radiographic  sign  of  osteoarthritis  but  its  signifi-
cance has been little explored. 
Subchondral  bone  is  made  up  of a  specialized 
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connective  tissue  formed  by  a  mineralized  matrix 
containing specific type I collagen, proteoglycans, and 
several growth factors, as well as bone specific cell 
types: osteoblasts, osteocytes, and osteoclasts. It has 
been  reported  that  OA  subchondral  bone  shows 
dysregulated osteoblast (3) and osteoclast phenotype 
(4) however, it is currently not known whether oste-
ocyte cells undergo phenotypic changes during  OA 
progression.  
Osteocytes  are  terminally  differentiated  osteo-
blasts  residing  within  the  mineralized  bone  matrix 
and make up more than 90-95% of all bone cells in the 
adult skeleton. The osteocyte-canalicular cell network 
is  now  considered  to  play  a  central  and  mul-
ti-functional  role  in  regulating  skeletal  homeostasis 
(5). The most accepted theory for osteocytic function 
places these cells as transducers of mechanical strains 
that are translated into biochemical signals affecting 
the  communication  among  osteocytes  and  between 
osteocytes  and  osteoblasts  or  osteoclasts  (6).  This 
cascade  of  events  may  ultimately  regulate  bone  re-
modelling  and  mineral  metabolism  (7).  Since  me-
chanical knee misalignment and altered joint geome-
try were known causes of OA (8), it is likely that os-
teocytes might undergo enormous changes given that 
their function is to act as transducers of mechanical 
strains. 
This  study  was  designed  to  understand  the 
pathophysiology of osteocyte network in OA patients 
by  determining  changes  in  osteocyte  morphology, 
distribution, apoptosis, and evaluating the expression 
of  osteocyte  markers  and  matrix  degradation  en-
zymes. The phenotypic changes of osteocytes in OA 
patients  were  evident  and  these  changes  might  be 
responsible for the active site-specific remodelling of 
subchondral  bone,  resulting  in  subchondral  bone 
thickening and dysregulated mineral metabolism. 
MATERIALS AND METHODS 
Patients 
OA patients undergoing total knee replacement 
were recruited for this study after informed consent 
was given. This study was approved by The Queens-
land  University  of  Technology  and  Prince  Charles 
Hospital  ethics  committees.  Patient  variables  i.e., 
height, weight and age were recorded and preopera-
tive  radiographs  of  the  knee,  anteroposterially  and 
laterally,  were  taken.  The  Subchondral  bone  was 
classified using scoring system set by The American 
College of Rheumatology (9). OA cartilage was classi-
fied  according  to  the  modified  Mankin  score  (10). 
According to the previous studies (11), the patients 
were  classified  as  OA  (n=5)  with  a  Mankin  score 
greater than 5 and normal control (n=5) with a score 
less than 3.  
Micro-CT 
Morphological changes of subchondral bone in 
control vs. OA specimens were determined using Mi-
cro-CT. Tibial plate samples were scanned with micro 
CT (Scanco 40, Switzerland) with isotropic voxel size 
of 18 μm after tissues were fixed in 4% paraformal-
dehyde (PFA) in PBS as scanning medium. The x-ray 
tube voltage was 55 kV and the current was 145 μA, 
with a 0.5 mm aluminium filter. The exposure time 
was  1180  ms.  The  data  set  was  segmented  with  an 
inbuilt software. In the medial and the lateral part of 
each  tibia,  a  volume  of  interest  (VOI)  was  selected 
with automatic contouring method. The circles were 
located  in  the  middle  of  the  load-bearing  and 
non-load  bearing  sites  of  subchondral  bone  areas. 
Selected areas contained subchondral plate, but did 
not  contain  subchondral  trabecular  bone  or 
growth-plate tissue. A total of 30 consecutive tomo-
graphic  slices  were  analysed.  The  meaningful  sub-
chondral  bone  plate  measurements  such  as  bone 
volume (mg HA/ccm) and BV/TV (%) were analysed 
using  inbuilt  software.  Subchondral  bone  thickness 
was measured quantitatively using Axio Vision soft-
ware by converting number of pixels to micro meters.  
Scanning electron microscopy (SEM) analysis 
for osteocytes 
SEM  and  backscatter  SEM  was  performed  as 
described earlier (12). For resin-casted SEM, samples 
were dissected and ﬁxed in 2.5% glutaraldehyde in 0.1 
M sodium cacodylate buffer containing 0.05% tannic 
acid.  The  tissue  specimens  were  dehydrated  in  as-
cending concentrations of ethanol (from 70% to 100%), 
embedded in methyl methacrylate, and then surface 
polished using 1 μm and 0.3 μm Alpha Micropolish 
Alumina  II  (Buehler)  in  a  soft-cloth  rotating  wheel. 
The  bone  surface  was  acid  etched  with  37%  phos-
phoric acid for 2–10 seconds, followed by 5% sodium 
hypochlorite for 5 min. The samples were then coated 
with gold and palladium as described previously (13) 
and  examined  using  an  FEI/Philips  XL30 
Field-Emission Environmental Scanning Electron Mi-
croscope. 
For  back-scattered  SEM  (BSEM),  the  samples 
were ﬁxed overnight in 2% paraformaldehyde and 2% 
glutaraldehyde buffered at pH 7.4 with 0.1 M sodium 
cacodylate. Samples were then rinsed three times (20 
min  each  time)  in  0.1  M  cacodylate  buffer  solution 
followed by secondary ﬁxation (1 h) in a solution of 
1% osmium tetroxide in 0.1 M cacodylate buffer. The 
BSEM  samples  were  then  coated  with  carbon  and Int. J. Biol. Sci. 2012, 8 
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examined using an FEI/ Philips XL30 Field-Emission 
Environmental Scanning Electron Microscope 
Histology tissue preparation 
All  samples  containing  any  overlying  cartilage 
and subchondral bone were dissected to an approxi-
mate depth of 1cm. All of the samples for histology 
and  immunohistochemical  analysis  were  washed  in 
saline  and  immediately  fixed  in  4  %  paraformalde-
hyde  for  24  hours.  The  samples  were  washed  in 
phosphate buffer solution (PBS) for one hour and then 
placed  in  10%  ethylene  diamine  tetraacetic  acid 
(EDTA)  for  decalcification.  The  EDTA  solution  (PH 
7.0) was changed weekly for four weeks and decalci-
fication  was  confirmed  by  radiographic  analysis. 
Tissue  specimens  were  embedded  in  paraffin  wax 
once the decalcification was complete. Tissue slices of 
5 µm thick were sectioned using microtome, placed on 
3-aminopropyltriethoxy-silane  coated  glass  slides, 
air-dried  and  stored  at  4  0C  prior  to  analysis.  Each 
specimen was H&E stained to visualize the general 
morphology.  
H&E staining 
Tissue slices were dewaxed in xylene and rehy-
drated in descending concentrations of ethanol (100% 
to  70%),  sections  were  then  stained  with  Mayers’s 
haemotoxylin for 1-2 minutes before washing with tap 
water for 5 minutes. The slides were dehydrated in 
ascending concentration of ethanol (70% to 100%) and 
stained  with  eosin  for  15 seconds  and  cleared  with 
xylene  and  mounted  on  DePeX  mounting  medium 
(BDH Laboratory Supplies, England). 
Immunohistochemistry 
Immunohistochemistry was carried out using an 
indirect  immunoperoxidase  method.  Tissue  slices 
were dewaxed in xylene and rehydrated. Endogenous 
peroxidases were blocked by incubation in 0.3% per-
oxide  for  30  min  followed  by  repeated  washing  in 
PBS. The sections were then incubated with protein-
ases  K  (DAKO  Multilink,  CA,  USA)  for 20  min  for 
antigen retrival. Next, all sections were treated with 
0.1%  bovine  serum  albumin  (BSA)  with  10%  swine 
serum in PBS. Sections were then incubated with op-
timal dilution of primary antibody overnight at 4 0C. 
Optimum  concentration  of  antibodies  was  deter-
mined by using a series of dilutions. After 24 hours, 
sections  were  incubated  with  a  biotinylated 
swine-anti-mouse, rabbit, goat antibody (DAKO Mul-
tilink, CA, USA) for 15 min, and then incubated with 
horseradish  perioxidase-conjugated  avidin-biotin 
complex for 15 min. Antibody complexes were visu-
alized by the addition of a buffered diaminobenzidine 
(DAB)  substrate  for  3  min  and  the  reaction  was 
stopped  by  rinsing  sections  in  PBS.  Sections  were 
counterstained with Mayer’s haematoxylin for 10 sec 
each, and rinsed with running tap water. Following 
this,  dehydrated  with  ascending  concentrations  of 
ethanol solutions, cleared with xylene and mounted 
with coverslip using DePeX mounting medium. Con-
trols  for  the  immunostaining  procedures  included 
conditions where the primary antibody and the sec-
ondary (anti-mouse IgG) antibodies were omitted. In 
addition, an irrelevant antibody (anti CD-15), which 
was  not  present  in  the  test  sections,  was  used  as  a 
control. A list of antibodies sources and dilutions used 
for this study are summarized in Table 1.  
 
Table 1: Details of antibodies and the working dilutions 
used in this study. 
Protein  Dilution  Source 
SOST  1:100  R & D systems 
DMP-1  1:1000  Gift from Prof Jian Feng 
MMP-9  1:150  Labvison, Fremont, CA 
ADAMTS4  1:100  Labvison, Fremont, CA 
MMP1  1:200  Labvison, Fremont, CA 
 
Resin embedding 
Undecalcified tissue samples were embedded in 
Poly-Methyl  methacrylate  (PMMA).  Samples  were 
dehydrated through a graded ethanol series and pro-
cessed  through  three  changes  of  xylene  then  infil-
trated with Methyl methacrylate (MMA) and subse-
quently incubated with a mixture of MMA and poly-
ethylene  glycol.  To  initiate  the  polymerisation  pro-
cess,  the  catalyst  Perkadox  (0.3%)  was  added  to 
MMA/PEG  (3%)  solution.  Samples  were  fully  cov-
ered  with  the  MMA/PEG/Perkadox  solution  and 
incubated at 50ºC for 10 min. Specimens were put to 
rest until fully polymerised. Embedded samples were 
cut into 5 μm sections using an automated sledge mi-
crotome  (Reichert-Jung,  Polycut  S),  stretched  with 
70%  ethanol  and  collected  onto  gelatine  coated  mi-
croscope slides. Sections were overlaid with a plastic 
film and slides were clamped together prior to drying 
for 12 h at 60ºC. Sections were deplastified in xylene, 
rehydrated  and  stained  using  von  Kossa  staining 
procedures  and  Goldner  staining  using  standard 
protocols.  
Distribution of osteocyte cell number and la-
cunae 
Subchondral bone plate was defined as starting 
from  the  calcified  cartilage  (CC)  bone  junction  and Int. J. Biol. Sci. 2012, 8 
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ending at the marrow space. Meaningful parameters 
to describe our area of interest were determined by 
measuring the thickness of the subchondral plate in 
all samples under 10 x magnification and calculating 
the average length (0.98mm) and calculating the av-
erage  area  (mm2).  Average  osteocyte  nucleus  (Avg 
OS.N)  and  average  osteocyte  empty  lacunae  (Avg 
OS.L) were counted per unit area, within the defined 
area of interest using AxioVision Rel 4.8 Software. The 
Avg OS.N and Avg OS. Lac between control and OA 
are represented in a bar graph.  
In situ cell death detection (apoptosis) using 
TUNEL 
Osteocyte apoptosis was assessed principally at 
single  cell  level,  based  on  labelling  of  DNA  strand 
breaks (Terminal deoxynucleotidyl transferase dUTP 
nick end labelling or TUNEL technology) using In Situ 
Cell  Death  Detection  Kit,  Fluorescein  (Roche,  Ger-
many)  according  to  manufacturer’s  protocol.  Tissue 
sections were permeabilised for 30min at 370C with 
Proteinase K solution (Roche, Germany). As a positive 
control, sections were treated with DNase1 for 10 min 
at room temperature prior to labelling procedure was 
used to induce DNA strand breaks. The tunel reaction 
mixture  /  terminal  transferace  was  omitted  for  the 
negative control. Subchondral bone plate was defined 
as  starting  from  the  calcified  cartilage  (CC)  bone 
junction and ending at the marrow space. Meaningful 
parameters to describe our area of interest were de-
termined by measuring the thickness of the subchon-
dral  plate  in  all  samples under  10  x  magnifications 
and calculating the average length (0.98mm) and cal-
culating the average area. TUNEL positive osteocyte 
was counted in 3 fields per section within the defined 
area of interest using AxioVision Rel 4.8 Software. The 
average  TUNEL  positive  osteocyte  between  control 
and OA are represented in a bar graph. 
Quantitative real time polymerase reaction 
(qPCR)  
qPCR was performed to detect the gene expres-
sion  differences  in  control  and  OA  bone  lysates. 
Briefly, for total RNA extraction, the fresh bone tis-
sues  were  obtained  from  OA  patients  (collected  in 
RNAse  later  solution)  and  graded  according  to  the 
disease severity. Small fragments of bone pieces were 
cut by using bone cutter and tissues were homoge-
nised  using  the  bead  beater  for  one  minute.  Total 
RNA was extracted using Trizol method and qPCR 
was performed as described previously (14, 15). The 
quality and integrity of the RNA extracted were con-
firmed on 1% wt/vol ethidium bromide-stained aga-
rose gels.  
Western blot  
Total tissue protein was harvested by lysing the 
subchondral bone in a lysis buffer containing 1 M Tris 
HCl (pH 8), 5 M NaCl, 20% Triton X-100, 0.5 M EDTA 
and  a  protease  inhibitor  cocktail  (Roche,  Dee  Why, 
NSW, Australia). The cell lysate was clarified by cen-
trifugation and the protein concentration determined 
by a bicinchoninic acid protein assay (Sigma-Aldrich). 
10  g  of protein  was separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis on a 12% 
gel.  The  protein  was  transferred  to  a  nitrocellulose 
membrane, and blocked in a Tris-Tween buffer con-
taining 5% non-fat milk. The membranes were incu-
bated with primary antibodies against ALP (1:1,000) 
and OCN (1:2,000) overnight at 4ºC. The membranes 
were washed three times in TBS-Tween buffer, and 
then  incubated  with  an  anti-rabbit  secondary  anti-
body at 1:2,000 dilutions for 1 hr. The protein bands 
were visualized using the ECL Plus™ Western Blot-
ting Detection Reagents (GE Healthcare, Rydalmere, 
NSW, and Australia) and exposed on X-ray film (Fu-
jifilm,  Stafford,  QLD,  Australia).  Immunoblot  nega-
tives were analyzed by densitometry using Image J 
software. 
Tartrate resistant acid phosphatase (TRAP) 
staining of paraffin embedded samples  
 
To detect osteoclast activity, TRAP staining was 
performed as described previously by Erlebacher et al 
(16). Paraffin sections of 5 μm thickness were depar-
affinised in two changes of xylene (8 min each) and 
rehydrated  (2  changes  95%  ethanol,  2  min  each;  1 
change 70% and 50% ethanol each 5 min, deionised 
water 5 min). After rehydration, samples were placed 
in 0.2 M Acetate Buffer (0.2 M sodium acetate and 50 
mM L(+) tartaric acid in ddH2O, pH 5.0) for 20 min at 
room temperature. Subsequently sections were incu-
bated  with  0.5  mg/ml  naphtol  AS-MX  phosphate 
(Sigma) and 1.1 mg/ml fast red TR salt (Sigma) in 0.2 
M  acetate  buffer  for  1-4  h  at  37ºC  until  osteoclasts 
appeared  bright  red.  Samples  were  counterstained 
with  Haematoxylin,  air  dried  and  mounted  with 
ProLong® Gold (Invitrogen) mounting solution. 
Statistical analysis  
Paired  Student’s  t-test  was  used  to  determine 
any significance between control vs. OA subchondral 
bone, by counting the % positive staining cells in the 
field of view for immunohistochemistry, by counting 
the Avg OS.N and Avg OS.L (per unit area), and for 
distribution  studies.  P≤0.05  was  considered  signifi-
cant.  Int. J. Biol. Sci. 2012, 8 
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RESULTS 
Patient demographics and specimen charac-
terization  
The mean age of all patients was 72 years (range 
63 – 79), mean weight was 93.4 kg (range 64-105) and 
mean height was 173 cm (range 162-185). H&E stain-
ing was performed to confirm the site specific changes 
in the samples. All control specimens showed normal 
appearing  articular  cartilage  with  underlying  sub-
chondral bone. The outer (radial) layer of noncalcified 
cartilage  (NC)  was  separated  from  the  underlying 
calcified cartilage (CC) layer by the tidemark (TM). 
Immediately adjacent to the CC was the subchondral 
bone plate (SB). In contrast, OA specimens showed 
cartilage loss with a small region on the edge of the 
slide where there was some preservation of the deep 
and middle zone cartilage layers. The NC was much 
thinner and the CC was relatively thicker in OA sam-
ples  when  compared  to  the  control  specimens. 
Therefore, the distance between the TM and the SB 
was  thicker  than  in  the  normal  specimens.  SB  ad-
vancement in the OA specimens was seen in all the 
patients  indicating  extensive  bone  remodeling.  Col-
lectively,  these  results  show  significant  site-specific 
changes in OA patients. 
Altered gene expression, micro-architectural 
and mineral properties in OA subchondral 
bone 
A  representative  of  the  3-D  reconstruction  of 
subchondral bone from micro-CT images (fig 1a, i-ii) 
showed significant changes in the microstructure of 
subchondral  bone  in  OA  patients.  Compared  with 
control,  OA  subchondral  bone  was  significantly 
thicker and denser with a plate like structure. Quan-
titative  micro-CT  data  revealed  that  OA  specimens 
had a 20% increase in bone volume fraction compared 
to the control group (p = 0.049) (fig 1a, iii). Similarly, 
an  increase  in  the  subchondral  bone  thickness  and 
mean density was observed in OA patients  (fig  1a, 
iv-v).  To  further  investigate  these  at  the  molecular 
level, it was noted that the mRNA (fig 1b, i-iii) and 
protein (fig 1b, iv) synthesis of alkaline phosphotase 
(ALP),  osteopontin  (OPN)  and  osteocalcin  (OCN) 
were significantly higher in OA samples compared to 
patient  matched  controls.  These  results  indicate  ab-
normal site-specific OA bone phenotypic properties. 
 
Figure 1: Micro-architectural and mineral properties in OA subchondral bone: A representative 3-D reconstructions of tibial 
bone specimens of control and OA from micro-CT scans (a, i-ii) and quantitative results show OA subchondral bone plate has a higher 
bone volume fraction, mineral content and thickness compared to control specimens (a, iii-v) . Molecular marker changes: qRT-PCR was 
used to measure the gene expression levels of ALP, OPN and OCN. ALP and OPN showed a significant increase in OA bone (b,i-iii). At 
the protein level, a similar trend was observed using western bolt (b,iv). Tubulin was used as an internal loading control. Bars equals 
meanﾱSD, n=5, *p≤0.05. Goldner staining of control and OA samples (c, i-ii). Von kossa stained sections (c,iii-iv). Back scatter SEM 
(BS-SEM) images (c, v-vi). Int. J. Biol. Sci. 2012, 8 
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Goldner staining showed that there were signif-
icantly  increased  un-mineralized  areas  (stained  or-
ange) in OA subchondral bone compared with con-
trols (fig 1c, i-ii). This was further confirmed by Von 
kossa  staining on the un-decalcified tissue  samples, 
which showed that the mineral content distribution 
was  significantly  altered  in  OA  subchondral  bone, 
showing increased less mineralized areas compared 
with controls (Black staining shows the distribution of 
mineral content and white shows the distribution of 
un-mineralized  areas)  (fig  1c,  iii-iv).  Similarly, 
backscatter SEM images showed significantly disor-
ganized mineral distribution compared with the con-
trols where the white/grey areas show the distribu-
tion of mineral content and the black areas show the 
lack of mineral content (fig 1c, v-vi).  
Distorted osteocyte distribution and mor-
phology in OA samples  
A representative H&E staining of the subchon-
dral bone of OA and patient matched control shows 
the histological appearance of osteocyte morphology, 
number and distribution. Arrows represent osteocyte 
nucleus and arrow heads represent empty osteocyte 
lacunae  (fig  2a,  i-ii).  Average  osteocyte  lacunae 
(Avg.OS.Lac)  density  was  significantly  increased  in 
the  OA  patients  compared  to  controls  (P  =  0.0041). 
However,  no  significant  differences  were  observed 
with  respect  to  Average  osteocyte  nucleus 
(Avg.OS.N) (P=0.0691) or viable osteocyte count (fig 
2a, iii-iv). We examined the morphology of OA oste-
ocytes using back scatter SEM (fig 2b, i-ii) and SEM 
(fig 2b, iii-vi) and it revealed that the osteocytes in 
OA samples were markedly deformed with a rough, 
lysed (fig 2b iv&vi) and rounded appearance (Fig 
2b, ii) with very few dendrites compared to spindle 
shaped  (fig  2b,  i),  well  organised  and  well  con-
nected  osteocytes  (fig  2b,  iii&v)  in  the  control 
specimens. Furthermore, mineral distribution was 
disorganised,  showing  woven  appearance  in  OA 
(fig 2b, ii) compared with well organised and con-
sistent mineral distribution in normal samples (fig 
2b, i). It was also noticed blood vessel invasion in 
OA subchondral bone (fig 2b, iv).  
 
 
Figure  2:  Disrupted  osteocyte  morphology  and  dis-
tribution in OA patients: H&E staining of the subchondral 
bone of OA and patient matched control showing the histo-
logical  appearance  of  osteocyte  morphology,  number  and 
distribution. Arrows represent osteocyte nucleus and arrow 
heads represent osteocyte lacunae (a, i-ii). OA subchondral 
plate  showed  no  significant  increase  in  the  Avg  OS.N  (P= 
0.0691) compared to control (a, iii). OA subchondral plate 
showed a significant increase in the Avg OS.Lac (P= 0.0041) 
compared  to  control  (a,  iv).  Bars  equal  mean±SD,  n=5, 
*p≤0.05.(b, i-ii) Back scatter image and (b, iii-vi) SEM images 
show  clear  morphological  differences  which  include  rough 
lysed and rounded appearance with fewer dendrites in OA 
osteocytes and blood vessel (arrows) invasion in OA samples 
(b, iv).  
 
Dysregulated osteocyte markers in OA os-
teocytes  
Osteocytes  selectively  express  sclerostin 
(SOST),  which  is  well  characterised  as  negative 
regulator  of  bone  formation.  We  performed  a 
comparative  immunohistochemical  analysis  of 
SOST expression in OA and patient matched con-
trol  samples.  When  quantified  by  assessing  the 
percentage  fraction  of  SOST-positive  osteocytes Int. J. Biol. Sci. 2012, 8 
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among  total  osteocytes,  major  differences  became 
evident. SOST expression was observed in more than 
half of the osteocytes in the control specimens but was 
significantly reduced in OA samples (P=0.001), indi-
cating a suppressed expression of this bone regulatory 
protein in OA (fig 3, a-b). In contrast to these findings 
the  expression  of  Dentin  Matrix  Protein  1  (DMP1, 
regulator  of  bone  mineralisation)  staining  was 
stronger  in  OA  osteocytes  and  the  percentage  of 
DMP1  positive  osteocytes  were  higher  in  OA  com-
pared to control specimens (P=0.0002) (fig 3, d-e). The 
expression of DMP1 and SOST has been correlated to 
the  ratio  of  bone  volume  to  total  volume  (BV/TV) 
showing that increase in bone volume was correlated 
with the expression of increased DMP1 and decreased 
SOST (fig 3, c&f).  
 
 
Figure 3: Expression of osteocyte markers and the correlation to BV/TV: Immunohistochemical analysis shows a decrease in 
the average % positive stained osteocytes for SOST in OA patients compared to controls (P=0.001) (a-b). and an increase in the average 
% positive stained osteocytes for DMP1 in OA patients compared to controls (P=0.003) (d-e) Correlation studies reveals that the 
expression of SOST decreases with the increase in bone volume to total volume (BV/TV) (c) and the expression of DMP1 increases with 
increase in BV/TV f). 
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Increased apoptosis and TRAP positive stain-
ing in OA osteocyte  
The number of average TUNEL and TRAP posi-
tive osteocytes was significantly higher in OA osteo-
cytes compared to controls. In OA subchondral bone 
there  were  increased  osteoclast  activity  showing 
TRAP positive (fig 4a, ii) compared to the control (fig 
4a,  i).  Interestingly,  osteocytes  in  OA  samples  also 
showed positive staining of TRAP (fig  4a,  iv) com-
pared with the controls (fig 4a, iii) , where osteocytes 
showed  negative  TRAP  staining.  A  representative 
TUNEL stained section showed more number of os-
teocytes undergoing apoptosis in OA samples (fig 4b, 
ii)compared  to  controls  (fig  4b,  i).  The  average 
TUNEL positive osteocyte between control and OA 
are represented in a bar graph (fig 4b, iii).  
Dysregulated expression of degradative en-
zyme expression in OA osteocytes  
Matrix metalloproteinases (MMPs) are well rec-
ognized as mediators of matrix degradation, and their 
activity by virtue of the cleavage of matrix substrates 
are  well  known.  We  showed  that  the  intensity  of 
MMP-1.  (fig  5,  a-c),  MMP-9  (fig  5,  d-f),  and 
ADAMTS4 (fig 5, g-i) signals were stronger and the 
percentage  of  positive  osteocytes  were  significantly 
higher  in  OA  samples  compared  to  control  patient 
specimens.  
 
Figure  4:  Defective  osteoclast  /  osteocyte 
TRAP  expression  and  increased  apoptosis 
(TUNEL positive) in OA osteocytes: A rep-
resentative  TRAP  stained  section  shows  an  in-
creased in the number of osteoclasts (a, i-ii). In-
creased TRAP positive osteocytes were observed in 
OA subchondral bone (a, iii-iv). A representative 
TUNEL stained section shows that more number of 
OA osteocytes are undergoing apoptosis compared 
to  controls.  Arrows  represent  TUNEL  positive 
osteocytes and arrow heads represents live/nuclear 
stain (b, i-ii). b, iii is the bar graph showing increased 
TUNEL  positive  OA  osteocytes.  Bars  equal 
meanﾱSD, n=5, *p≤0.05. 
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Figure 5: Dysregulated expression of degradative enzymes: Significant increase in the average percentage positive stained os-
teocytes in OA samples was observed with (a-c) MMP1 (p=0.001), (d-f) MMP9 (p=0.0026), (g-i) ADAMTs4 (p=0.0042) compared controls. 
Bars equal meanﾱSD, (n=5), *p≤0.05. 
 
 
DISCUSSION 
Subchondral  bone  sclerosis  is  a  major 
patho-physiological manifestation of OA, and it is still 
unknown if it precedes cartilage breakdown in this 
disease. Regardless of whether bone sclerosis is the 
initiating event, it perturbs the overlying cartilage in 
OA patients; therefore, preventing subchondral bone 
sclerosis  may  contribute  to  improving  the  comfort 
and mobility of OA patients (17). It is now evident 
that subchondral bone cells such as osteoblasts and 
osteoclasts  undergo  significant  changes  in  OA  (18). 
However, recent studies emphasise the importance of 
osteocyte in maintaining the bone homeostasis. Stud-
ies  have  demonstrated  that  osteocytes  regulate  the 
behaviour  of  osteoblasts  and  osteoclasts  by  com-
municating through gap junctions (19). With this ev-
idence, we hypothesised that osteocyte function may 
be hampered in OA leading to OA osteocyte pheno-
type  and  this  could  play  an  important  pathological 
role in subchondral bone sclerosis. Our findings sug-
gest that the various functional properties of osteo-
cytes appear to be changed in patients with OA.  
In OA, the increase in bone volume, density, and 
stiffening of subchondral bone has been reported and 
the possible reason for this change might be due to 
bone  remodelling  in  response  to  repetitive  mi-
cro-damage/fracture  as  a  result  of  an  imbalance  in 
mechanical loading of the joint (20). In this study we 
identified that OA subchondral bone showed an in-
creased bone volume and the bone mineral content 
was  significantly  altered.  We  further  demonstrated 
that  these  subchondral  bone  changes  in  OA  were 
correlated with the expression of osteocyte markers, 
which showed decreased SOST and increased DMP1 
expression  in  OA  samples.  Osteocyte  expression  of 
SOST is a delayed event and it is produced only by 
mature  osteocytes  after  they  become  embedded  in Int. J. Biol. Sci. 2012, 8 
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matrix that has been mineralized. From then on, ma-
ture osteocytes appear to express SOST whether they 
are located in osteons or bone. SOST knockout mice 
have a progressive high bone mass phenotype (21, 22). 
The precise physiological role of SOST in osteocytes is 
not yet fully understood, but numerous studies indi-
cate that loss of SOST expression enhances osteogen-
esis  (23).  Currently,  it  is  thought  that  SOST  passes 
through  the  osteocytic  canalicular  network  to  the 
bone surface where it inhibits osteoblastic canonical 
Wnt/beta-catenin  signaling,  which  is  implicated  in 
bone  mass  regulation  (24-26).  Therefore,  decreased 
SOST expression in OA osteocytes may be responsible 
for  the  increased  bone  volume  in  OA  subchondral 
bone.  
In contrast to the expression of SOST, increased 
expression of DMP1 can induce impairment in min-
eralization (27, 28) with poorly organized mineral and 
an apparent delay in the transition from osteoblasts to 
osteocytes. In this study it was found that OA sub-
chondral  bone  showed  significant  dysregulation  in 
mineral metabolism. This may be due to the increased 
expression  of  DMP1  in  OA  osteocytes.  DMP-1  is  a 
secretory  protein  and  an  osteocyte  marker  essential 
for normal postnatal chondrogenesis and subsequent 
osteogenesis  (29).  In  vivo  studies  have  shown  that 
DMP1 actively participates in bone homeostasis and 
mineralization  and  mechanical  loading  stimulates 
DMP1 expression in osteocytes (30-32). It can be as-
sumed that increased expression of DMP1 in OA os-
teocytes may disrupt the normal mineralization pro-
cess in OA subchondral bone, resulting in increased 
osteoid  volume  and  irregular  mineralization  of  OA 
subchondral  bone.  The  surprising  finding  of  de-
creased SOST and increased DMP1 expression in OA 
osteocytes may be indicative of elevated bone turno-
ver resulting in increased subchondral bone volume 
in OA samples - a characteristic feature of OA. Indeed, 
we demonstrated that bone turnover markers (ALP, 
OPN, OCN, MMPs, TRAP) were significantly upreg-
ulated in OA samples compared with controls, indi-
cating an underlying potential mechanism leading to 
OA subchondral bone changes.   
Osteocytes and their connections are highly dy-
namic, as observed by their constant contraction and 
expansion of osteocyte bodies within the lacunae and 
by  the  extension  and  retraction  of  dendrites  thus 
adapting mechanical load (33). This may imply that 
the  shape  of  osteocytes  is  determined  by  external 
loading and imbalanced mechanical stimulation can 
lead  to  morphological  changes.  Our  SEM  results 
showed  that  OA  subchondral  bone  osteocytes  (OA 
osteocyte phenotype) were more rounded, rough and 
were not aligned in any particular direction, however, 
the patient matched control samples showed spindle 
shaped  and  uniformly  aligned  osteocytes  (Normal 
osteocyte phenotype). These results indicate that an 
irregular  morphology  of  osteocytes  increases  OA 
predilection and this might alter the ability of bone to 
sense  mechanical  stimuli  leading  to  significant 
changes in the structure and mineral density. It could 
be  interpreted  as  a  phenomenon  where  the  signals 
passing through osteoblasts and osteoclasts could be 
hampered.  Indeed,  increased  osteogenic  activities 
(ALP, OPN and OCN expression) and increased os-
teoclastic activity (TRAP statining) were noted in OA 
subchondral bone. 
An adequate number of osteocytes are essential 
to remove bone microdamage, and the osteocyte den-
sity correlates  with the quality of bone (34). In this 
study  we  found  that  average  osteocyte  lacunae 
(Avg.OS.Lac) number was significantly higher in OA 
bone compared to normal’s, however no significant 
differences were observed with respect to total num-
ber  of  osteocyte  nucleus  count.  This  could  be  ex-
plained by the increased osteocyte apoptosis, showing 
TUNEL positive osteocytes in OA samples.  
Our results clearly showed the rough, lysed and 
rounded appearance of the lacunae and canaliculi of 
osteocytes  in  OA  samples.  To  adapt  to  mechanical 
stimuli,  osteocytes  modulate  their  mechanical  envi-
ronment by regulating their attachment to the matrix 
(35). MMPs are well recognized as mediators of ma-
trix  degradation,  and  their  activity  by  virtue  of  the 
cleavage of matrix substrates are well known. As ex-
pected,  we  found  that  MMP-1,  MMP-9  and 
ADAMTS4  were  all  significantly  increased  in  OA 
compared  to  control  giving  a  possible  indication  to 
assume that the osteocyte morphology will corrode its 
coupling  to  the  matrix  by  producing  digestive  en-
zymes  such  as  MMPs.  The  function  of  osteocyte 
through death and the expression of MMPs in bone 
remodelling and joint disease has been emphasised by 
various independent researchers (36-38). Role of os-
teocytes in the regulation of bone resorption has been 
largely unknown. TRAP staining has been regarded 
as  one  of  the  reliable  markers  of  osteoclasts.  Few 
studies have shown the expression of TRAP in oste-
ocytes close to the bone resorbing surface and its rela-
tion to MMPs (39-41). With this in view, TRAP posi-
tive and MMPs positive osteocytes may control the 
direction of osteoclastic resorption in OA subchondral 
bone. However, these results need further investiga-
tion to understand the cellular  interactions between 
TRAP positive osteocytes and osteoclasts during bone 
resorption. Another limitation of the study is the rela-
tively  small  sample  size  of  human  samples.  Even 
though  the  osteocyte  changes  are  obvious  as  evi-Int. J. Biol. Sci. 2012, 8 
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denced  in  the  five  OA  samples,  validation  studies 
with larger sample sizes need to be performed.  
CONCLUSION 
Our study provides evidence that OA osteocyte 
phenotype  has  distinctive  changes  both  phenotypi-
cally and morphologically. We conclude that the OA 
osteocyte phonotypic changes participate in OA sub-
chondral bone pathogenesis. These characteristic OA 
changes  could  be  caused  by  the  activa-
tion/deactivation of osteocyte signalling molecules in 
the OA microenvironment.  
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